Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: Single-cell profiling reveals a reduced epithelial defense system, decreased immune responses and the immune regulatory roles of different fibroblast subpopulations in chronic atrophic gastritis

Fig. 6

ASPN is an early upregulated marker in the CAG stage of gastric tumorigenesis. (A) Venn plot of conservatively upregulated markers, color-coded by patient. (B) Feature plot of ASPN gene expression (gray to red) in fibroblast clusters; CAG: left panel; control: right panel. (C) Boxplots showing ASPN expression levels between different disease conditions in public datasets (GSE130823, GSE191275, TCGA-STAD dataset). (D) Boxplot showing ASPN expression levels between different disease conditions in GSE153224. (E) Boxplot showing ASPN expression levels detected by RT‒PCR in CAG and corresponding control samples (n = 5). P values were calculated via the two-sided Wilcoxon test. (F) Volcano plot showing the DEGs between APSN-positive CCL11+APOE+ fibroblasts and ASPN-negative CCL11+APOE+ fibroblasts. (G) Representative mIHC staining of ASPN. CAG and control tissues were stained with DCN (red), ASPN (green), and DAPI for DNA (blue)

Back to article page